/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

L

Loretta J. Nastoupil

The University of Texas MD Anderson Cancer Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

721

Papers

18.7K

Citations

59

h-index

239

i10-index

Loretta J. Nastoupil is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & CAR-T cell therapy research & Chronic Lymphocytic Leukemia Research. The author has an h-index of 59, co-authored 613 publications.

ORCID: 0000-0001-6071-8610

Research Topics

Lymphoma Diagnosis and Treatment CAR-T cell therapy research Chronic Lymphocytic Leukemia Research Viral-associated cancers and disorders CNS Lymphoma Diagnosis and Treatment

Papers by this author

works

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

2024 · Nature Medicine · 403 citations

https://doi.org/10.1038/s41591-023-02785-8

David Marín Ye Li Rafet Başar Hind Rafei

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

2023 · Nature Medicine · 213 citations

https://doi.org/10.1038/s41591-023-02234-6

Christoph K. Stein‐Thoeringer Neeraj Saini Eli Zamir Viktoria Blumenberg

Single-Institution Experience in the Treatment of Primary Mediastinal B Cell Lymphoma Treated With Immunochemotherapy in the Setting of Response Assessment by 18Fluorodeoxyglucose Positron Emission Tomography

2015 · International Journal of Radiation Oncology*Biology*Physics · 59 citations

https://doi.org/10.1016/j.ijrobp.2015.02.006

Chelsea C. Pinnix Bouthaina S. Dabaja Mohamed Ahmed Hubert H. Chuang

Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies

2024 · Blood · 56 citations

https://doi.org/10.1182/blood.2024025454

Laurie H. Sehn Nancy L. Bartlett Matthew J. Matasar Stephen J. Schuster

Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma

2018 · British Journal of Haematology · 50 citations

https://doi.org/10.1111/bjh.15720

Brian T. Hill Loretta J. Nastoupil Allison Winter Melody Becnel

Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study

2023 · Journal of Hematology & Oncology · 43 citations

https://doi.org/10.1186/s13045-023-01508-3

Narendranath Epperla Lei Feng Nirav N. Shah Lindsey Fitzgerald

Research topics

topics

Lymphoma Diagnosis and Treatment

CAR-T cell therapy research

Chronic Lymphocytic Leukemia Research

Viral-associated cancers and disorders

CNS Lymphoma Diagnosis and Treatment

Chat about Author

Papers

Chat

Click to start Chat